Current trends in tuberculosis vaccine

Journal Title: Medical Journal Armed Forces - Year 2019, Vol 75, Issue 1

Abstract

Despite the global efforts made to control tuberculosis (TB) and the large number of available new anti-TB drugs, TB still affects one-third of the world population. The conventional vaccine bacille CalmetteeGuerin (BCG) shows varying efficacy in different populations, and there are safety issues in immunocompromised patients. Hence, there is an urgent requirement for a new and better TB vaccine candidate than BCG. There are several alternate vaccines available for TB such as DNA, subunit, adjuvant, and live-attenuated vaccines. Use of auxotrophic vaccine is an emerging technology. Newer vaccine technologies include vaccine delivery methods such as adenovirus- and cytomegalovirus (CMV)-based vector delivery, chimeric monoclonal antibody, single-chain fragment variable, RNAlipoplexes, and nanoparticle-based technology. Based on its application, TB vaccines are classified as conventional, prophylactic, booster, therapeutic, and reinfection preventive vaccines. Currently, there are 12 vaccine candidates in clinical trials. In this review, we have briefly discussed about each of these vaccines in different phases of clinical trials. These vaccines should be analyzed further for developing a safe and more efficacious vaccine for TB.

Authors and Affiliations

Srikanth P. Tripathy

Keywords

Related Articles

Filaria surveys in the Armed Forces: Need for a revisit

Background: Routine annual filarial surveys are conducted amongst various categories of military personnel and their families as per policies in vogue in the Armed Forces. The neglect and inattention faced by this diseas...

Communicable diseases viewed as collateral damage: Role of primary prevention in their prevention and control

Communicable disease incidence may be seen as ‘collateral damage’ of our choices or compulsions, whether it is our behavior, religious or ethnic group we belong to, occupation we indulge in, geographical area we live in...

Anti tubercular therapy induced liver function tests abnormalities in human immunodeficiency virus infected individuals

Background: Both antitubercular therapy (ATT) and antiretroviral therapy (ART) can cause drug induced liver injury (DILI) in tuberculosis (TB) and human immunodeficiency virus (HIV) coinfection. The aim of this research...

Aeromedical solutions for aerospace safety

All facets of activity in the speciality of Aviation Medicine are essentially aimed at enhancing aerospace safety. This paper highlights some innovative changes brought about by Aerospace Medicine in the three major fiel...

Measles, mumps, and rubella: A cross-sectional study of susceptibility to vaccine-preventable diseases among young people in India

Background: Global elimination of vaccine preventable diseases, such as measles, mumps and rubella is a priority. Many countries have reported diminishing of antibody titres against these diseases among young population...

Download PDF file
  • EP ID EP664438
  • DOI 10.1016/j.mjafi.2018.12.013
  • Views 75
  • Downloads 0

How To Cite

Srikanth P. Tripathy (2019). Current trends in tuberculosis vaccine. Medical Journal Armed Forces, 75(1), 18-24. https://europub.co.uk./articles/-A-664438